<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>NNN Buzz - Latest pharma stocks India News &amp; Blogs</title>
    <link>https://www.nnnbuzz.com/topic/pharma%20stocks%20India</link>
    <description>Stay updated with the latest pharma stocks India articles, blogs, and stories from NNN Buzz</description>
    <language>en-US</language>
    <lastBuildDate>Sat, 23 May 2026 05:19:35 GMT</lastBuildDate>
    <managingEditor>admin@nnnbuzz.com (NNN Buzz)</managingEditor>
    <webMaster>admin@nnnbuzz.com (NNN Buzz)</webMaster>
    <ttl>15</ttl>
    <generator>Keynate Topic RSS Generator</generator>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.nnnbuzz.com/topic/pharma%20stocks%20India/rss" rel="self" type="application/rss+xml" />
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.nnnbuzz.com/topic/pharma%20stocks%20India" rel="alternate" type="text/html" />
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" rel="hub" href="https://pubsubhubbub.appspot.com/" />
    <image>
      <title>NNN Buzz - Latest pharma stocks India News &amp; Blogs</title>
      <url>https://www.nnnbuzz.com/apple-touch-icon.png</url>
      <link>https://www.nnnbuzz.com/topic/pharma%20stocks%20India</link>
      <width>96</width>
      <height>96</height>
    </image>
    <item>
      <title>Glenmark pharma shares in focus on Monday after $29.6 million US antitrust settlement</title>
      <link>https://www.nnnbuzz.com/news/glenmark-pharma-shares-in-focus-on-monday-after-usd-29-6-million-us-antitrust-settlement</link>
      <description>&lt;a href="https://www.nnnbuzz.com/news/glenmark-pharma-shares-in-focus-on-monday-after-usd-29-6-million-us-antitrust-settlement"&gt;&lt;img alt="Glenmark pharma shares in focus on Monday after $29.6 million US antitrust settlement" src="https://www.nnnbuzz.com/view/aman/untitled-design-14.jpg"&gt;&lt;/a&gt;&lt;p&gt;Glenmark Pharma shares will be in focus on Monday after the company settled a US antitrust litigation case for $29.6 million, payable over five years.&lt;/p&gt;</description>
      <category>Glenmark Pharma shares</category>
      <category>Glenmark Pharmaceuticals</category>
      <category>Glenmark Pharma stock price</category>
      <category>Glenmark US antitrust case</category>
      <category>Glenmark settlement</category>
      <category>Glenmark Pharma news</category>
      <category>pharma stocks India</category>
      <category>Glenmark share news</category>
      <category>Glenmark USA litigation</category>
      <category>stock market news India</category>
      <pubDate>Sat, 23 May 2026 05:19:35 GMT</pubDate>
      <guid>https://www.nnnbuzz.com/news/glenmark-pharma-shares-in-focus-on-monday-after-usd-29-6-million-us-antitrust-settlement</guid>
    </item>
  </channel>
</rss>
